The behavior of corporate executives to mislead investors and shareholders through the manipulation of internal information usually involves violations of laws and ethical standards. Its core purpose is to seek short-term benefits through information asymmetry (such as raising stock prices, obtaining bonuses or stock option gains). The following are some typical methods and their potential effects. It should be emphasized that these behaviors are illegal and harm market fairness.： ###1. Common manipulation methods 1. **Selective disclosure** -**Exaggeration of positive information**: Deliberately release one-sided positive news (such as R&D progress, unsuccessful cooperation intentions) in advance to cover up potential risks. -**Delay in negative information**: Postpone the disclosure of financial losses, litigation risks or regulatory investigations, and take advantage of the time difference to complete the stock sell-off or financing. 2. **Financial data manipulation** -**Inflated revenue**: False reporting of revenue through related-party transactions, false sales contracts, or loopholes in revenue recognition rules. -**Cost concealment**: Capitalize operating expenses and use off-balance sheet entities to transfer debt (such as the case of Enron). 3. **Insider trading and market manipulation** -Executives use undisclosed information to buy and sell stocks (for example, sell stocks before the earnings report is released). -Release misleading expectations through the media or analysts, cooperate with funds to drive up the stock price and then cash out. 4. **Strategic misleading** -Fictitious long-term strategic planning (such as exaggerating investment in new technologies or market expansion plans), but actual resources are not invested. -Conceal information that affects the fundamentals of the company such as the departure of core executives and changes in regulatory policies. ###2. Actual case reference -**The Enron incident (2001)**: Concealed debts through special purpose entities (SPEs) and falsely reported profits of more than US11 billion. -**Ruixing Coffee (2020)**: Forged sales of RMB2.2 billion, and the stock price plunged by 80%. -**Theranos (2015)**: Exaggerated the effectiveness of blood testing technology and deceived investors of nearly 1 billion U.S. dollars. ###3. Legal consequences and market impact -**Legal risks**: May violate the false statements and insider trading provisions of the Securities Law (such as the Sarbanes Act of the United States and Article 161 of the Chinese Criminal Law) and face criminal penalties and civil compensation. -**Collapse of market trust**: Long-term market capitalization shrinks after short-term stock price fluctuations, corporate financing costs rise, and even bankruptcy liquidation. ###4. How investors can prevent 1. **Penetrating analysis**: Compare the difference between cash flow and profit, and pay attention to related-party transactions and off-balance sheet liabilities. 2. **Regulatory dynamic tracking**: Pay attention to risk signals such as changes in audit institutions, abnormal shareholding reductions by senior executives, and regulatory inquiries. 3. **Diversification of investment**: Avoid excessive dependence on the “story” of a single enterprise and pay attention to the overall risks of the industry. Any act of profiting from information manipulation is market fraud, and global regulatory agencies (such as the SEC and the China Securities Regulatory Commission) have strengthened their crackdown through big data monitoring and reporting mechanisms. Investors need to improve their ability to identify information and protect their rights and interests.